Sources | Names Used |
---|---|
GDSC1000, GRAY, FIMM | Bortezomib |
gCSI, CTRPv2 | bortezomib |
PharmacoGx | Bortezomib |
Database | Identifier |
---|---|
Smiles: | B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O |
Inchikey: | GXJABQQUPOEUTA-RDJZCZTQSA-N |
Pubchem: | 387447 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TMEM59L | GDSC1000 | pan-cancer | AAC | -0.16 | 0.005 |
mRNA | TAS2R42 | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
mRNA | ME3 | FIMM | pan-cancer | AAC | 0.39 | 0.005 |
mRNA | ZSCAN23 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | SFTPC | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | ZC3H7A | FIMM | pan-cancer | AAC | -0.45 | 0.005 |
mRNA | COA5 | gCSI | pan-cancer | AAC | -0.17 | 0.005 |
mRNA | PLEKHF1 | FIMM | pan-cancer | AAC | 0.41 | 0.005 |
mRNA | MSRB1 | gCSI | pan-cancer | AAC | -0.17 | 0.005 |
mRNA | RADIL | GDSC1000 | pan-cancer | AAC | -0.17 | 0.005 |